ROYAL BANK OF CANADA - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$72,000
+166.7%
6,323
+139.3%
0.00%
Q2 2023$27,000
+170.0%
2,642
+99.1%
0.00%
Q1 2023$10,000
-56.5%
1,327
-57.9%
0.00%
Q4 2022$23,000
+2200.0%
3,155
+1560.5%
0.00%
Q3 2022$1,0000.0%190
+115.9%
0.00%
Q2 2022$1,000
-83.3%
88
-87.7%
0.00%
Q1 2022$6,000
-83.3%
713
-72.7%
0.00%
Q4 2021$36,000
+200.0%
2,612
+120.8%
0.00%
Q3 2021$12,000
+71.4%
1,183
+48.8%
0.00%
Q2 2021$7,000795
+9837.5%
0.00%
Q4 2020$0
-100.0%
8
-92.2%
0.00%
Q3 2020$1,000
-98.8%
103
-98.8%
0.00%
Q2 2020$81,000
+440.0%
8,353
+56.1%
0.00%
Q1 2020$15,000
+1400.0%
5,351
+2031.9%
0.00%
Q4 2019$1,0000.0%251
-29.7%
0.00%
Q3 2019$1,0000.0%357
+42.8%
0.00%
Q2 2019$1,000
-80.0%
250
-66.7%
0.00%
Q1 2019$5,000
+66.7%
7500.0%0.00%
Q4 2018$3,000
-40.0%
7500.0%0.00%
Q3 2018$5,000
-16.7%
7500.0%0.00%
Q2 2018$6,0000.0%7500.0%0.00%
Q1 2018$6,000
-25.0%
7500.0%0.00%
Q4 2017$8,000
+166.7%
750
+198.8%
0.00%
Q3 2017$3,0002510.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$32,400,0002.50%
Omega Fund Management, LLC 1,284,900$16,190,0002.43%
Avidity Partners Management LP 1,248,000$15,725,0000.51%
Samsara BioCapital, LLC 399,190$5,030,0000.51%
EcoR1 Capital, LLC 741,290$9,340,0000.50%
DAFNA Capital Management LLC 113,202$1,426,0000.42%
TIGER MANAGEMENT L.L.C. 137,728$1,735,0000.39%
Orbimed Advisors 3,070,955$38,694,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 198,260$2,498,0000.22%
Artal Group S.A. 593,030$7,472,0000.16%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders